Journal of Cardiac Failure
Volume 16, Issue 5 , Pages 369-373, May 2010

The Sympathorenal Axis in Hypertension and Heart Failure

  • Steven R. Goldsmith, MD

      Affiliations

    • Cardiology Division, Hennepin County Medical Center and University of Minnesota, Minneapolis, MN
    • Corresponding Author InformationReprint requests: Steven R. Goldsmith, MD, Hennepin County Medical Center, 701 Park Avenue So., Minneapolis, MN 55415. Tel: 612-873-2876; Fax: 612-904-4224
  • ,
  • Paul A. Sobotka, MD

      Affiliations

    • Research Division, Hennepin County Medical Center and University of Minnesota, Minneapolis, MN
  • ,
  • Bradley A. Bart, MD

      Affiliations

    • Cardiology Division, Hennepin County Medical Center and University of Minnesota, Minneapolis, MN

Received 10 September 2009; received in revised form 10 December 2009; accepted 30 December 2009. published online 22 February 2010.

Abstract 

Excessive sympathetic drive is undoubtedly a major contributing factor to the pathophysiology of hypertension and heart failure. Much of the excessive sympathetic drive in these conditions is directed to the kidney, where it leads to inappropriate sodium retention, renin stimulation, and diminished renal function. Less well appreciated is the role the kidney itself plays in the generation of increased sympathetic activity by way of the renal somatic afferent nerves. The kidney therefore is both target and contributor to increased sympathetic activity in these conditions. Although some current pharmacotherapy indirectly targets this “sympathorenal axis,” resistant hypertension remains a common problem, and the prognosis in heart failure remains poor, especially in more severe cases. It is now possible to directly target this axis via procedures, which directly interrupt renal sympathetic efferent and afferent signaling. Other procedures involving chronic carotid nerve stimulation may indirectly influence renal sympathetic tone and so improve renal sodium handling. These techniques have demonstrated early promise in hypertension and offer significant potential in heart failure as well. Should their early promise be borne out in controlled studies, the “sympathorenal axis” will have been proven to be a key element in the pathophysiology of these 2 very common, and dangerous, conditions.

Key Words: Sympathetic nervous system, renal sympathetic nerves, hypertension, heart failure

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 See page 372 for disclosure information.

PII: S1071-9164(09)01242-1

doi:10.1016/j.cardfail.2009.12.022

Journal of Cardiac Failure
Volume 16, Issue 5 , Pages 369-373, May 2010